Search Results (1 to 10 of 3197 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 890 Journal of Medical Internet Research
- 621 JMIR Research Protocols
- 347 JMIR Formative Research
- 302 JMIR mHealth and uHealth
- 143 JMIR Public Health and Surveillance
- 116 JMIR Mental Health
- 86 JMIR Medical Informatics
- 84 JMIR Human Factors
- 84 Online Journal of Public Health Informatics
- 71 JMIR Cancer
- 53 JMIR Serious Games
- 51 JMIR Pediatrics and Parenting
- 46 JMIR Aging
- 45 JMIR Medical Education
- 33 Interactive Journal of Medical Research
- 29 JMIR Rehabilitation and Assistive Technologies
- 28 JMIR Perioperative Medicine
- 27 JMIR Diabetes
- 24 JMIR Dermatology
- 18 JMIR Cardio
- 18 JMIR Infodemiology
- 13 Iproceedings
- 12 JMIR AI
- 12 JMIR Nursing
- 10 JMIR Bioinformatics and Biotechnology
- 10 JMIRx Med
- 10 Journal of Participatory Medicine
- 4 JMIR Biomedical Engineering
- 3 Asian/Pacific Island Nursing Journal
- 3 Medicine 2.0
- 2 JMIR Neurotechnology
- 2 JMIR XR and Spatial Computing (JMXR)
- 0 iProceedings
- 0 JMIR Preprints
- 0 JMIR Challenges
- 0 JMIR Data
- 0 JMIRx Bio
- 0 Transfer Hub (manuscript eXchange)
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section

The higher dropout rate in the intervention group yields a greater proportion of NAs relative to the control group.
c€1=US $1.08.
d ASKU: Allgemeine Selbstwirksamkeit Kurzskala.
ee HEALS: e Health Literacy Scale.
f SCA: symptom checker app.
Trial profile outlining the total number of patients screened, randomized, completing study surveys at multiple time points during their stay, and included in the primary end point analysis.
J Med Internet Res 2025;27:e64028
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section

Exclusion criteria (any 1 of these disqualifies an individual from participating)
Any contraindications to the use of combined oral contraceptives (COCs) according to the current summary of product characteristics of Effimia, that is, women presenting (or having ever presented) with myocardial infarction, transient ischemic attack, stroke, angina pectoris, deep vein thrombosis, pulmonary embolism (or presence of blood clots in organs other than legs and lungs), any blood clotting disorder (such as protein C
JMIR Res Protoc 2025;14:e63683
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section